NCT07313202 2025-12-31
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
1 trialsPatients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE × ivarmacitinib × Other solid neoplasm × Clear all